Is Lipoprotein(a) an Independent Risk Factor for Ischemic Heart Disease in Men? The Quebec Cardiovascular Study
- 1 March 1998
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 31 (3) , 519-525
- https://doi.org/10.1016/s0735-1097(97)00528-7
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Risk factors for restenosis after percutaneous transluminal coronary angioplasty: Role of lipoprotein (a)American Heart Journal, 1995
- Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction.Heart, 1995
- Elevated Serum Lipoprotein(a) Is a Risk Factor for Clinical Recurrence After Coronary Balloon AngioplastyCirculation, 1995
- Rapid Angiographic Progression of Coronary Artery Disease in Patients With Elevated Lipoprotein(a)Circulation, 1995
- Quantitation of Plasma Apolipoproteins in the Primary and Secondary Prevention of Coronary Artery DiseaseAnnals of Internal Medicine, 1994
- Lipoprotein(a) Levels and Risk of Coronary Heart Disease in MenJAMA, 1994
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menThe American Journal of Cardiology, 1992
- Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.Journal of Clinical Investigation, 1992
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsAtherosclerosis, 1991
- Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.BMJ, 1990